-
Analyst Opinions
Agile IT – How Software-Defined Everything (SDx) Transforms Enterprise Fabric
Software-Defined Everything (SDx) Technology Overview Software-Defined Everything (SDx) is the key to managing enterprise IT infrastructure challenges. SDx technologies enable dynamic resource allocation, centralized management, security enhancement, agile provisioning, and integration with modern applications, fostering infrastructure efficiency and resilience. "Agile IT - How Software-Defined Everything (SDx) Transforms Enterprise Fabric" innovation radar report explores the pervasive influence of software-defined technologies across various sectors such as automotive, technology, telecom, aerospace & defense, manufacturing, energy & power, and consumer & retail. This report...
-
Thematic Analysis
Banking Predictions for 2024 – Thematic Intelligence
Exploring in-depth trends and insights from the ‘Banking Predictions for 2024’ report will enable you to: Analyze the major themes that will impact the banking industry in 2024. Identify the top 20 themes impacting the banking industry – artificial intelligence, cybersecurity, the future of work, cloud computing, blockchain and cryptocurrencies, fintech, internet of things, big data, social media, financial wellness, digital lending, digital banking, conversational platforms, personalization, data privacy, and open banking. Understand a wide range of disruptive themes that...
-
Product Insights
Leukocyte Disorders (White Blood Cell Disorders) – Drugs In Development, 2023
Global Markets Direct’s, ‘Leukocyte Disorders (White Blood Cell Disorders) - Drugs In Development, 2023’, provides an overview of the Leukocyte Disorders (White Blood Cell Disorders) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Leukocyte Disorders (White Blood Cell Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Dilated Cardiomyopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Dilated Cardiomyopathy - Drugs In Development, 2023’, provides an overview of the Dilated Cardiomyopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dilated Cardiomyopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Fanconi Anemia – Drugs In Development, 2023
Global Markets Direct’s, ‘Fanconi Anemia - Drugs In Development, 2023’, provides an overview of the Fanconi Anemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fanconi Anemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cardiomyopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Cardiomyopathy - Drugs In Development, 2023’, provides an overview of the Cardiomyopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cardiomyopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
Chile Foodservice Market Size and Trends by Profit and Cost Sector Channels, Players and Forecast to 2027
Chile Foodservice Market Report Overview The Chile foodservice profit sector recorded sales of CLP6,523.7 billion ($7.5 billion) in 2022 and is forecast to record a healthy CAGR of over 12% during 2022-2027. The economic revival and government initiatives to promote cultural and wine tourism in the region will eventually benefit on-premises foodservice operations in the country. Chile Foodservice Profit Sector Outlook 2022-2027, (CLP Billion) Buy the Full Report for More Insights on the Chile Foodservice Market Forecast Download A Free...
-
Product Insights
NewNet Present Value Model: Rocket Pharmaceuticals Inc’s RPA-501
Empower your strategies with our Net Present Value Model: Rocket Pharmaceuticals Inc's RPA-501 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.